Dipexium Pharmaceuticals, Inc. (DPRX)

Recent filings

Dipexium Pharmaceuticals, Inc. insider just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - Oct. 4, 2017

Financial Statements and - Sept. 28, 2017

Dipexium Pharmaceuticals: Plx Pharma Hires Key Commercial Executives In Preparation For Future Launch Of Aspertec - Sept. 19, 2017

Confidential treatment order - Aug. 21, 2017

Financial Statements and - Aug. 15, 2017

Dipexium Pharmaceuticals, Inc.'s CEO was just granted 86,872 options - Aug. 14, 2017

Dipexium Pharmaceuticals, Inc.'s Executive Chairman just picked up 30,000 shares - Aug. 14, 2017

Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Aug. 11, 2017

Entry into Material - Aug. 10, 2017

Dipexium Pharmaceuticals, Inc.'s Chief Financial Officer just declared 60,000 options - July 11, 2017

Notice of Exempt Offering of Securities, item 06b - June 28, 2017

Ronald R. Zimmerman just provided an update on share ownership of Dipexium Pharmaceuticals, Inc. - June 22, 2017

Major owner of Dipexium Pharmaceuticals, Inc. just declared owning 1,075,723 shares of Dipexium Pharmaceuticals, Inc. - June 19, 2017

Peter S. Park just provided an update on share ownership of Dipexium Pharmaceuticals, Inc. - June 19, 2017

Major owner of Dipexium Pharmaceuticals, Inc. just picked up 32,727 shares - June 16, 2017

Major owner of Dipexium Pharmaceuticals, Inc. just picked up 7,273 shares - June 16, 2017

Dipexium Pharmaceuticals, Inc.'s Executive Chairman just picked up 29,091 shares - June 16, 2017

Dipexium Pharmaceuticals: Announces Pricing Of Registered Direct Offering Houston, Texas, June - June 12, 2017

Dipexium Pharmaceuticals, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 12, 2017

VP of Dipexium Pharmaceuticals, Inc. just declared 45,000 options - May 5, 2017

Dipexium Pharmaceuticals: Report Of Independent Registered Public Accounting Firm Consolidated - May 5, 2017

Dipexium Pharmaceuticals: ’Connor Appointed Chief Financial Officer Of Plx Pharma - May 2, 2017

Ronald R. Zimmerman just provided an update on share ownership of Dipexium Pharmaceuticals, Inc. - May 1, 2017

Dipexium Pharmaceuticals, Inc. director was just granted 275,000 options - April 21, 2017

Dipexium Pharmaceuticals, Inc.'s President and CEO just picked up 1,086 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just picked up 2,190 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s Acting Chief Financial Officer just picked up 119,186 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s Chief Operating Officer just picked up 87,946 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s Executive Chairman just picked up 93,295 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just picked up 5,445 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just picked up 1,675 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just picked up 2,710 shares - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s Acting Chief Financial Officer just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s Executive Chairman just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s President and CEO just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s Chief Operating Officer just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc. director just declared ownership of no shares of Dipexium Pharmaceuticals, Inc. - April 20, 2017

Dipexium Pharmaceuticals, Inc.'s Chief Accounting Officer was just granted 130,000 options - April 20, 2017

Plx Pharma And Dipexium Pharmaceuticals Complete Merger - April 20, 2017

Major owner of Dipexium Pharmaceuticals, Inc. was just granted 183,332 options - April 20, 2017

Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: NOTE 10 — NET LOSS... - April 17, 2017

Dipexium Pharmaceuticals, Inc. Just Received a Notice of Effectiveness - March 17, 2017

Dipexium Pharmaceuticals, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 17, 2017

Registration of securities, business combinations - Feb. 28, 2017

Jason H. Karp just issued a filing suggesting it has sold all of its Dipexium Pharmaceuticals, Inc. - Feb. 14, 2017

Mark Kingdon just issued a filing suggesting it has sold all of its Dipexium Pharmaceuticals, Inc. - Feb. 14, 2017

Dipexium Pharmaceuticals, Inc. Just Filed Its Annual Report: NOTE 10 — ... - Jan. 20, 2017

PLx Pharma Inc. just provided an update on activist position in Dipexium Pharmaceuticals, Inc. - Jan. 3, 2017

Dipexium Pharmaceuticals: Dipexium And Plx Pharma Announce Merger Agreement - Dec. 22, 2016

Prospectuses and communications, business combinations - Dec. 22, 2016

Departure of Directors or Certain - Dec. 14, 2016

Departure of Directors or Certain - Nov. 16, 2016

Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: NOTE 9 — NET LOSS... - Nov. 9, 2016

Dipexium Pharmaceuticals: Dipexium Announces Top-Line Data From - Oct. 31, 2016

Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: NOTE 9 — NET LOSS... - Aug. 3, 2016

Securities to be offered to employees in employee benefit plans - July 7, 2016

Submission of Matters to a Vote of Security - May 26, 2016

Dipexium Pharmaceuticals Announces Completion Of Enrollment Objective In Onestep-2 Pivotal Phase 3 Clinical Trial And First Quarter 2016 Financial Results - May 12, 2016

Quarterly report [Sections 13 or 15(d)] - May 11, 2016

Dipexium Pharmaceuticals, Inc. releases salary data. CEO sees compensation fall -60% - April 4, 2016

Other preliminary proxy statements - March 23, 2016

Dipexium Pharmaceuticals Reports 2015 Financial Results - March 23, 2016

Annual report [Section 13 and 15(d), not S-K Item 405] - March 22, 2016

Dipexium Pharmaceuticals, Inc.'s Chief Accounting Officer was just granted 65,000 options - Jan. 21, 2016

Major owner of Dipexium Pharmaceuticals, Inc. was just granted 35,000 options - Jan. 21, 2016

Dipexium Pharmaceuticals, Inc. director was just granted 18,000 options - Jan. 21, 2016

Dipexium Pharmaceuticals, Inc. director was just granted 18,000 options - Jan. 21, 2016

Dipexium Pharmaceuticals, Inc. director was just granted 18,000 options - Jan. 21, 2016

Major owner of Dipexium Pharmaceuticals, Inc. was just granted 35,000 options - Jan. 21, 2016

Dipexium Pharmaceuticals, Inc. director was just granted 18,000 options - Jan. 21, 2016

Dipexium Pharmaceuticals, Inc. director was just granted 18,000 options - Jan. 21, 2016

Dipexium Pharmaceuticals, Inc.'s VP Finance & Corp. Dev was just granted 35,000 options - Jan. 21, 2016

Dipexium Pharmaceuticals: January 2016 Commercializing A Low-Risk, Late-Stage Compound - Jan. 11, 2016

Dipexium Pharmaceuticals Reports Third Quarter 2015 Financial Results - Nov. 16, 2015

Dipexium Pharmaceuticals Reports Second Quarter 2015 Financial Results - Aug. 13, 2015

Dipexium Pharmaceuticals: General Instruction A.2. Below) - July 20, 2015

Dipexium Pharmaceuticals: Dipexium Announces Closing Of Public Offering Of Common Stock - June 30, 2015

Dipexium Pharmaceuticals, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 25, 2015

Dipexium Pharmaceuticals: Printing And Engraving Expenses - June 25, 2015

Prospectus [Rule 424(b)(5)] - June 24, 2015

Dipexium Pharmaceuticals, Inc. Just Received a Notice of Effectiveness - June 19, 2015

Registration statement under Securities Act of 1933 - June 9, 2015

Dipexium Pharmaceuticals: General Instruction A.2. Below) - May 19, 2015

Dipexium Pharmaceuticals Reports First Quarter 2015 Financial Results - May 14, 2015

Other definitive proxy statements - April 1, 2015

Dipexium Pharmaceuticals,: Dipexium Pharmaceuticals Reports 2014 Financial Results - March 24, 2015

Dipexium Pharmaceuticals, Inc. Just Filed Its Annual Report: NOTE 12—NET LOSS ... - March 23, 2015

Dipexium Pharmaceuticals, Inc. director was just granted 15,000 options - Feb. 18, 2015

Dipexium Pharmaceuticals, Inc. director just declared owning 19,810 shares of Dipexium Pharmaceuticals, Inc. - Feb. 3, 2015

Dipexium Pharmaceuticals, Inc. director was just granted 15,000 options - Feb. 2, 2015

VP of Dipexium Pharmaceuticals, Inc. was just granted 35,000 options - Jan. 29, 2015

Dipexium Pharmaceuticals, Inc.'s Chief Accounting Officer was just granted 35,000 options - Jan. 29, 2015

Dipexium Pharmaceuticals, Inc. director was just granted 15,000 options - Jan. 29, 2015

Major owner of Dipexium Pharmaceuticals, Inc. was just granted 35,000 options - Jan. 29, 2015

Dipexium Pharmaceuticals, Inc. director was just granted 15,000 options - Jan. 29, 2015

Dipexium Pharmaceuticals, Inc. just filed a General Statement of acquisition of beneficial ownership - Nov. 28, 2014

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. LONE STAR VALUE INVESTORS, LP 171,661 4.4 Sept. 30, 2016
2. Russell Frank Co/ 91,185 N/A Sept. 30, 2015
3. Russell Frank Co/ 82,415 N/A Dec. 31, 2015
4. BlackRock Fund Advisors 15,733 N/A Sept. 30, 2016
5. Bank of New York Mellon Corp 14,092 N/A Dec. 31, 2016
6. WELLS FARGO & COMPANY/MN 12,000 N/A Sept. 30, 2016
7. MORGAN STANLEY 4,027 N/A Dec. 31, 2016
8. MORGAN STANLEY 3,783 N/A March 31, 2017
9. BlackRock Investment Management, LLC 956 N/A Dec. 31, 2016
10. Ground Swell Capital, LLC 606 N/A June 30, 2014
11. FIRST NEW YORK SECURITIES LLC /NY 500 N/A Dec. 31, 2016
12. UBS Group AG 430 N/A March 31, 2017
13. BANK OF AMERICA CORP /DE/ 196 N/A Sept. 30, 2016

Dipexium Pharmaceuticals, Inc. (DPRX)

140
 


Feedback